Tag: pharmacogenomics

Leveraging The Direct-to-Patient Research Model in Rheumatoid Arthritis

Janssen Healthcare Innovation, a unit of Janssen Research & Development, LLC, is sponsoring a study in rheumatoid arthritis patients that will be conducted by MediGuard.org (a subsidiary of Quintiles) and 23andMe. The study, called TogetherRA, will enroll approximately 1,000 patients who are currently ...

Read more

Father Knows Best

My parents aren’t world-class athletes, but in the summer of 2009 they both competed in the Senior Olympics. They were representing their home state of Wyoming, where people — much less senior athletes — are few and far between. It was at the Senior Olympics that my parents first encountered 23andMe. The ...

Read more

SNPWatch: Variants Associated with Clopidogrel Efficacy and Stent Thrombosis

Bakers know that some recipes are more complicated than others; some recipes require numerous ingredients, exact measurements and careful preparation, while others, such as my favorite peanut butter and jelly sandwich “recipe,” require very little. Similarly, some medical conditions are influenced by more ...

Read more

A Prescription for Personalizing Medicine

While a lot of the discussion about personalized medicine is focused on the future, Felix Frueh of Medco Health Solutions believes the most promising possibilities for individualized care could be implemented right now. Knowing a person’s underlying genetics with currently available tests could make ...

Read more

23andMe Launches Its First NIH Funded Study

  By Amy Kiefer and Kim Barnholt 23andMe is excited to announce the launch of our first National Institutes of Health (NIH) funded research project. In the fall of 2010, 23andMe received a NIH Small Business Innovative Research Grant (SBIR) to validate our web-based approach to pharmacogenomics ...

Read more

Health at 23andMe: When One Size Doesn’t Fit All

“Take two aspirin and call me in the morning.” That statement used to be a popular way to characterize the practice of medicine, back in the golden age of pharmaceuticals when drugs were seen as the answer to all problems. These days, we know that the picture is more complicated -- some conditions remain ...

Read more

Genetic Tests Can Reduce Risks From Blood Thinner Warfarin

Editor’s note: Pending an FDA decision, 23andMe no longer offers new customers access to health reports referred to in this post. Customers who purchased prior to November 22, 2013 will still be able to see their health reports, but those who purchased after that time will not. Those customers will have ...

Read more

Large Study Reveals Details of African American Genetic Ancestry

As shown in these ancestry paintings from 23andMe, the proportion of African DNA can vary widely for African Americans. A recent study led by Carlos Bustamante of Cornell and Sarah Tishkoff of the University of Pennsylvania has shown that genetically speaking, African American can mean a lot of different ...

Read more

Medco to Include Genetics in Comparison of Anti-Clotting Drug Effectiveness

Medco Health Solutions, Inc., announced this week that it will conduct a clinical trial to assess whether clopidogrel bisulfate (Plavix®, Bristol-Myers Squibb and Sanofi-aventis) is just as effective as the newer drug prasugrel (Effient™, Eli Lilly and Company) in people who lack a genetic variation that ...

Read more

Biotech Company Applies for FDA Permission to Market Gene-Targeted Heart Failure Drug

Researchers are sometimes frustrated when a prospective drug proves effective in some patients, but not enough to justify giving it to everyone who has the condition it is intended to treat. The beta-blocker drug bucindolol met that fate in 2001 when it was originally tested as a treatment for heart ...

Read more

Return to top